PREVENTION OF TRANSMISSION OF HIV BY ORGAN AND TISSUE-TRANSPLANTATION - HIV TESTING PROTOCOL AND A PROPOSAL FOR RECOMMENDATIONS CONCERNING DONOR SELECTION

被引:12
作者
PATIJN, GA [1 ]
STRENGERS, PFW [1 ]
HARVEY, M [1 ]
PERSIJN, G [1 ]
机构
[1] RED CROSS BLOOD TRANSFUS SERV,CENT LAB NETHERLANDS,PLESMANLAAN 125,1066 CX AMSTERDAM,NETHERLANDS
关键词
HIV; ORGAN AND TISSUE TRANSPLANTATION; DONOR SELECTION; TRANSMISSION;
D O I
10.1007/BF00336363
中图分类号
R61 [外科手术学];
学科分类号
摘要
Human immunodeficiency virus (HIV) can be transmitted by solid organ and some forms of tissue transplantation. Although routine screening of organ and tissue donors for anti-HIV antibodies was implemented in most Western European countries and North America in 1985, several recent case reports indicate that a definite, albeit very small, risk of HIV transmission still remains. The screening tests that are currently used cannot rule out a false-negative test result occurring during the window period. Moreover, massive transfusion of the donor during the donor procedure may result in an undetectable anti-HIV antibody titer (by dilution of donor blood) that consequently leads to a false-negative test result. These risks of HIV transmission via transplantation and important issues in HIV testing are discussed in detail. Furthermore, several recommendations for the prevention of transmission and a protocol for HIV testing for both organ and tissue donation are presented. These may serve as intermediary guideliness until official ones, such as already exist for blood donation, are defined by the transplantation communities. The exclusion of donors whose behavior may place potential recipients at risk for HIV infection is essential. A thorough heteroanamnesis of the donor's next of kin during the donor procedure should provide sufficient information about donor history to enable a decision to be made in this respect. Special attention is given to the question of whether the existing donor selection criteria for blood donation should be applied in a similar way to organ donation since the strict application of selection criteria may limit the number of available donor organs. This is highly recommended in the case of tissue transplantation, which does not usually imply a sense of urgency and, thus, allows more time for donor control and selection.
引用
收藏
页码:165 / 172
页数:8
相关论文
共 59 条
[1]  
Allain J.P., Laurian Y., Paul D.A., Senn D., Serologic markers in early stages of human immunodeficiency virus infection in haemophiliacs, Lancet, 2, pp. 1233-1236, (1986)
[2]  
Alter H.J., Epstein J.S., Swenson S.G., Van Raden M.J., Ward J.W., Kaslow R.A., Menitove J.E., Klein H.G., Sandler S.G., Sayers M.H., Prevalence of human immunodeficiency virus type 1 p24 antigen in US blood donors — an assessment of the efficacy of testing in donor screening, N Engl J Med, 323, pp. 1312-1317, (1990)
[3]  
Backer U., Weinauer F., Gathof G., Eberle J., HIV antigen screening in blood donors, Lancet, 2, pp. 1213-1214, (1987)
[4]  
Barri Y.M., Ellis M.E., Al-Furayh O., Qunibi W., Taher S., Al-Sabban E., Bernvil S.E., Renal transplantation associated with HIV infection: a Saudi Arabian experience and review of the literature, Clin Transplant, 5, pp. 233-240, (1991)
[5]  
Brun-Vezinet F., Rey M.A., Katlama C., Girard P.M., Roulot D., Yeni P., Lenoble L., Clavel F., Alizon M., Gadelle S., Lymphoadenopathy-associated virus type 2 in AIDS and AIDS-related complex, Lancet, 1, pp. 128-132, (1987)
[6]  
Buck B.E., Resnick L., Shah S.M., Malinin T.I., Human immunodeficiency virus cultured from bone. Implications for transplantation, Clin Orthop, 251, pp. 249-253, (1990)
[7]  
Busch M.P., Taylor P.E., Lenes B.A., Kleinman S.H., Stuart M., Stevens C.E., Tomasulo P.A., Allain J.P., Hollingworth C.G., Mosley J.W., Screening of selected male blood donors for p24 antigen of human immunodeficiency virus type 1, N Engl J Med, 323, pp. 1308-1312, (1990)
[8]  
Carbone L., Cohen D., Hardy M., Benvenisty A., Scully B., Appel G., Determination of acquired immunodeficiency syndrome (AIDS) after renal transplantation, Am J Kidney Dis, 11, pp. 387-392, (1988)
[9]  
Revised recommendations for prevention of human immunodeficiency virus (HIV) transmission by blood and blood products. Section I, parts A and B. Letter to registered blood establishments, (1990)
[10]  
Acquired immunodeficiency syndrome (AIDS) in persons with hemophilia (update), MMWR, 33, pp. 589-591, (1984)